SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-149852
Filing Date
2011-05-25
Accepted
2011-05-25 09:26:58
Documents
6
Period of Report
2011-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 23284
2 FORM OF WARRANT dex41.htm EX-4.1 71164
3 FORM OF THE SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 197741
4 FORM OF THE REGISTRATION RIGHTS AGREEMENT dex102.htm EX-10.2 96694
5 PRESS RELEASE dex991.htm EX-99.1 9484
6 GRAPHIC g191878g14q89.jpg GRAPHIC 14944
  Complete submission text file 0001193125-11-149852.txt   420273
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 11869663
SIC: 2834 Pharmaceutical Preparations